ALFA Finder
18:28 IST
BSE
Management Change
Trident Texofab Management Change
Trident Texofab Limited has appointed M/s. A Bafna & Associates as the new Statutory Auditor for a term of 12 months.
Trident Texofab Ltd
- Share price
- ₹22.57
- Market cap
- ₹33.85 Cr
- Revenue (annual)
- ₹118.0 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- -108.0×Sector 48.2×
- Promoter holding
- 32.88%+0.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Promoter Buying 4Financial Results 4Board Meeting Date 4Credit Rating 3Board Meeting Outcome 3Annual General Meeting 3Management Change 2Price Movement Clarification 1Debt & Borrowing 1Capital Structure Change 1
Time
2 announcements with these filters
20:49 IST
BSE
Management Change
Trident Texofab Management Change
Trident Texofab Limited announced the resignation of its statutory auditor, Shah Kailash & Associates LLP, effective August 10, 2026, due to increasing professional workload.